Viewing Study NCT01937260


Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2025-12-26 @ 12:26 AM
Study NCT ID: NCT01937260
Status: COMPLETED
Last Update Posted: 2017-04-10
First Post: 2013-07-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Brodalumab Drug-Drug Interaction (DDI) and Intensive Pharmacodynamic (PK) Study in Psoriasis Subjects
Sponsor: Bausch Health Americas, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 20110184
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators